The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8633196, 19 ID: ALA3648903
Chembl Id: CHEMBL3648903
PubChem CID: 49847472
Max Phase: Preclinical
Molecular Formula: C26H33N5O5S
Molecular Weight: 527.65
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCN1CCN([C@@H](CNS(=O)(=O)c2ccc(OCc3cc(C)nc4ccccc34)cc2)C(=O)NO)CC1
Standard InChI: InChI=1S/C26H33N5O5S/c1-3-30-12-14-31(15-13-30)25(26(32)29-33)17-27-37(34,35)22-10-8-21(9-11-22)36-18-20-16-19(2)28-24-7-5-4-6-23(20)24/h4-11,16,25,27,33H,3,12-15,17-18H2,1-2H3,(H,29,32)/t25-/m0/s1
Standard InChI Key: UFNKXVJYCDHZQW-VWLOTQADSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 527.65Molecular Weight (Monoisotopic): 527.2202AlogP: 1.91#Rotatable Bonds: 10Polar Surface Area: 124.10Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.72CX Basic pKa: 7.29CX LogP: 1.60CX LogD: 1.48Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -1.44
References 1. (2014) Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics, 2. (2016) Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics,